Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia

To evaluate the recurrence and postoperative complications rates after conjunctival autograft surgery using fibrin adhesive for primary pterygium

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pterygium Conjunctival Diseases Disease Attributes Eye Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Primary Recurrence

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sadalla Amin Ghanem Eye Hospital

Joinville, Santa Catarina, 89201-010, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of primary pterygium
Symptomatic pterygium
Limbal invasion

Exclusion criteria

Secondary pterygium

Treatment and study plan

Conjunctival autograft using fibrin glue

Procedure

Conjunctival autograft using fibrin glue in pterygium surgery

Other names: Pterygium surgery using fibrin glue

Primary outcomes

Recurrence of pterygium after its excision with the conjunctival autograft technique.

Time frame: One, three and five months after surgery.

Secondary outcomes

Postoperative complications following the pterygium excision, such as partial graft detachment, dellen, granuloma or sutures failure.

Time frame: One day, one week and one month after surgery.

Sponsors and collaborators

Lead sponsor

Hospital de Olhos Sadalla Amin Ghanem

Other

Registry information

Important dates

Study start: 2006
Primary completion: 2008
Study completion: 2009
First posted: Jul 30, 2009
Registry last updated: Jul 30, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed